文献速递先天性心脏病外科心外重症与机械循环支持

先天性心脏病、原发性电疾病或儿童心肌病年轻患者植入式心律转复除颤器的获益与风险

Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy†.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

本研究回顾2001至2023年214例先天性心脏病、儿童心肌病或原发性电疾病患者的除颤器植入情况,中位随访5.7年。41%患者接受恰当治疗,二次预防指征者5年发生率56%高于一级预防的26%(P=0.003);不恰当放电累积发生率13%,36%需非计划手术,腹部发生器及心外膜/心外导线为风险因素。

要点

  • 二次预防指征患者5年恰当治疗率56%,显著高于一级预防的26%
  • 不恰当放电累积发生率13%,先天性心脏病患者更常受累
  • 36%患者需非计划手术,腹部发生器及心外膜/心外导线为风险因素

核心结论

  • 恰当治疗率高,强调ICD选择时风险评估的重要性,尤其需减少导线故障和不必要放电。
  • 除颤器治疗伴随相当比例的非计划手术,腹部发生器和心外膜/心外导线为风险因素。

研究设计与样本

  • 回顾性分析2001至2023年植入除颤器的先天性心脏病、儿童心肌病或原发性电疾病患者,共214例。
  • 中位植入年龄23岁(四分位距15-38),中位随访5.7年(95%CI 4.9-7.3),196例纳入结局分析。

主要发现

  • 41%(n=80)患者接受恰当治疗,二次预防指征者5年发生率56%高于一级预防的26%(P=0.003)。
  • 不恰当放电累积发生率13%(n=26),先天性心脏病患者更常受累。
  • 36%(n=71)患者需非计划手术,主要因腹部发生器放置者的导线相关问题。

关键数值与推荐

  • 恰当治疗:41%(n=80);二次预防vs一级预防5年发生率56% vs 26%(P=0.003)。
  • 不恰当放电累积发生率13%(n=26);非计划手术36%(n=71)。

临床怎么用

  • 对先天性心脏病、儿童心肌病或原发性电疾病患者选择ICD时,应评估恰当治疗与不恰当放电风险。
  • 考虑避免腹部发生器及心外膜/心外导线以降低非计划手术风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to investigate the benefits and potential risks of implantable cardioverter-defibrillators in paediatric and congenital heart disease (CHD) patients in the current era. METHODS: All patients with CHD, paediatric cardiomyopathy or primary electrical disease, who underwent implantation of a defibrillator from 2001 to 2023, were examined. The occurrence of appropriate therapy, unplanned surgeries due to device complications, inappropriate shocks and associated risk factors were analysed. RESULTS: A total of 214 patients were included, with 61% having CHD, 17% having paediatric cardiomyopathy and 22% having primary electrical disease. The most common diagnoses were transposition of the great arteries and tetralogy of Fallot (each 12%). The median age at implantation was 23 years (interquartile ranges 15-38), and the median follow-up was 5.7 years (95% confidence interval 4.9-7.3). A total of 196 patients met the criteria for outcome analysis, where appropriate therapy was observed in 41% (n = 80), occurring more often in patients with indications for secondary prevention than primary prevention (56% vs 26% at 5 years, P = 0.003). The cumulative incidence of inappropriate shocks was 13% (n = 26), with patients with CHD being more frequently affected. Unplanned surgeries were required in 36% (n = 71), predominantly due to lead-related issues in those with abdominal generator placement. CONCLUSIONS: The high rate of appropriate therapies underscores the critical importance of risk assessment in ICD selection, particularly to mitigate lead failures and unnecessary shocks. However, defibrillator therapy has a relevant rate of unplanned surgeries, with abdominal generators and epicardial/extracardiac leads being risk factors.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Fetcu A, Schaeffer T, Niedermaier C, et al. Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy†. Eur J Cardiothorac Surg. 2025. PMID: 40220317. doi:10.1093/ejcts/ezaf134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。